This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Efficacy and safety of BIA 9-1067 in idiopathic Pa...
Clinical trial

Efficacy and safety of BIA 9-1067 in idiopathic Parkinson�s disease patients with �wearing-off� phenomenon treated with levodopa plus a dopa decarboxylase inhibitor (DDCI): a double-blind, randomised, placebo-controlled, parallel-group, multicentre clinic

Read time: 1 mins
Last updated:30th Nov 2010
To investigate the efficacy of 2 different doses of BIA 9-1067 (25 mg and 50 mg), administered once a day, compared with placebo when administered with the existing treatment of L-DOPA plus a DDCI, in patients with PD and end-of-dose motor fluctuations.
Category Value
Study start date 2010-11-30

View full details